Testing an experimental drug for bronchiectasis
Part of Lungs & breathing clinical trials.
This study tests a new medicine for people with non-cystic fibrosis bronchiectasis. It aims to see if the drug can help reduce symptoms and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have been diagnosed with bronchiectasis (widened airways) that is not caused by cystic fibrosis
- You weigh at least 110 pounds if female, or 110 pounds if male
- You are not a current smoker and have not smoked in the last 3 months
- You have not taken antibiotics by mouth or inhaled in the last 4 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, HSK31858, for people with non-cystic fibrosis bronchiectasis (a lung condition causing chronic cough and infections). It aims to see if the drug reduces lung flare-ups and improves symptoms.
This trial checks how other drugs affect RSS0343, a tablet being studied. You may qualify if you are a healthy adult who can avoid certain foods and medications during the study.
This study is looking at people with bronchiectasis (a lung condition that causes coughing and mucus) to understand how different types of inflammation in sputum (mucus from the lungs) affect their health over time. It may help find better treatments for those with frequent lung infections.
This study tests an oral tablet called RSS0343 for people with moderate to severe COPD. It aims to see if the tablet can improve lung function and reduce flare-ups when added to your current breathing treatments.
This trial tests if a new drug, GSK3862995B, is safe and effective for adults with bronchiectasis. It might help reduce lung infections and improve symptoms.
This trial tests an inhaled medication called CSL787 to see if it can help people with non-cystic fibrosis bronchiectasis (a lung condition that causes frequent infections and breathing problems). The study looks at different doses and checks how well the drug works and if it is safe.
Hear when a new Adolescent Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.